136 related articles for article (PubMed ID: 10999774)
21. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.
Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T
Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919
[TBL] [Abstract][Full Text] [Related]
22. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
23. Human c-fos promoter mediates high-level, inducible expression in various mammalian cell lines.
Bi JX; Buhr P; Zeng AP; Wirth M
Biotechnol Bioeng; 2003 Mar; 81(7):848-54. PubMed ID: 12557318
[TBL] [Abstract][Full Text] [Related]
24. Modification of growth in small heat shock (hsp27) gene transfected breast carcinoma.
Kindas-Mügge I; Micksche M; Trautinger F
Anticancer Res; 1998; 18(1A):413-7. PubMed ID: 9568111
[TBL] [Abstract][Full Text] [Related]
25. High HSP90 expression is associated with decreased survival in breast cancer.
Pick E; Kluger Y; Giltnane JM; Moeder C; Camp RL; Rimm DL; Kluger HM
Cancer Res; 2007 Apr; 67(7):2932-7. PubMed ID: 17409397
[TBL] [Abstract][Full Text] [Related]
26. The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells.
Seng S; Avraham HK; Jiang S; Yang S; Sekine M; Kimelman N; Li H; Avraham S
Cancer Res; 2007 Sep; 67(18):8596-604. PubMed ID: 17875699
[TBL] [Abstract][Full Text] [Related]
27. Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.
den Hollander P; Rayala SK; Coverley D; Kumar R
Cancer Res; 2006 Nov; 66(22):11021-9. PubMed ID: 17108141
[TBL] [Abstract][Full Text] [Related]
28. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells.
Lemieux P; Oesterreich S; Lawrence JA; Steeg PS; Hilsenbeck SG; Harvey JM; Fuqua SA
Invasion Metastasis; 1997; 17(3):113-23. PubMed ID: 9702938
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
31. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells.
Ritter LM; Garfield SH; Thorgeirsson UP
Biochem Biophys Res Commun; 1999 Apr; 257(2):494-9. PubMed ID: 10198240
[TBL] [Abstract][Full Text] [Related]
32. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.
Liu WM; Guerra-Vladusic FK; Kurakata S; Lupu R; Kohwi-Shigematsu T
Cancer Res; 1999 Nov; 59(22):5695-703. PubMed ID: 10582687
[TBL] [Abstract][Full Text] [Related]
33. Ectopic expression of (Mm)Kin17 protein inhibits cell proliferation of human tumor-derived cells.
Biard DS; Kannouche P; Lannuzel-Drogou C; Mauffrey P; Apiou F; Angulo JF
Exp Cell Res; 1999 Aug; 250(2):499-509. PubMed ID: 10413603
[TBL] [Abstract][Full Text] [Related]
34. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis.
He L; Yu JX; Liu L; Buyse IM; Wang MS; Yang QC; Nakagawara A; Brodeur GM; Shi YE; Huang S
Cancer Res; 1998 Oct; 58(19):4238-44. PubMed ID: 9766644
[TBL] [Abstract][Full Text] [Related]
35. In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells.
Samuel SK; Spencer VA; Bajno L; Sun JM; Holth LT; Oesterreich S; Davie JR
Cancer Res; 1998 Jul; 58(14):3004-8. PubMed ID: 9679963
[TBL] [Abstract][Full Text] [Related]
36. Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines.
Spencer VA; Samuel SK; Davie JR
Cancer Res; 2000 Jan; 60(2):288-92. PubMed ID: 10667578
[TBL] [Abstract][Full Text] [Related]
37. Effect of nucleolar P120 expression level on the proliferation capacity of breast cancer cells.
Fonagy A; Swiderski C; Ostrovsky AM; Bolton WE; Freeman JW
Cancer Res; 1994 Apr; 54(7):1859-64. PubMed ID: 8137301
[TBL] [Abstract][Full Text] [Related]
38. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations.
Jupe ER; Liu XT; Kiehlbauch JL; McClung JK; Dell'Orco RT
Cell Growth Differ; 1996 Jul; 7(7):871-8. PubMed ID: 8809404
[TBL] [Abstract][Full Text] [Related]
39. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors.
Brattsand G
Br J Cancer; 2000 Aug; 83(3):311-8. PubMed ID: 10917544
[TBL] [Abstract][Full Text] [Related]
40. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
Oesterreich S; Weng CN; Qiu M; Hilsenbeck SG; Osborne CK; Fuqua SA
Cancer Res; 1993 Oct; 53(19):4443-8. PubMed ID: 8402609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
